- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Non-opioid analgesia as effective as opioid analgesia after kidney stone surgery
In a new study conducted by Mathew Demasi and colleagues, it was shown that after kidney stone surgery, non-opioid analgesia (Ketorolac) is not inferior to opioid analgesia (acetaminophen/oxycodone).
The findings of this study were published in the Journal of Urology.
Opioids are frequently used to treat postoperative pain. Non-narcotic options are increasingly being utilized to minimize opioid consumption. This paper presents the findings of a randomized clinical trial evaluating non-opioid therapy to opioid therapy following nephrolithiasis surgery.
Between July 2018 and May 2021, patients having elective ureteroscopy or percutaneous nephrolithotomy were randomly assigned to either Ketorolac (Group A) or Acetaminophen/Oxycodone (Group B) (Group B). One week after surgery, each patient was queried by phone to measure pain results using an 11-point ordinal rating scale questionnaire. Patient demographics, surgery factors, pill count, constipation frequency, and any adverse effects were also recorded. To compare pain ratings between groups, a non-inferiority analysis was done using the Mann-Whitney U-Test with a non-inferiority margin of 1.3.
The key findings of this study were as follow:
1. A total of 90 patients had complete data, with 44 (49%) in group A and 46 (51%) in group B.
2. In terms of demographics, kind of stone removal operation, whether or not a stent was put, and stone burden, both groups were comparable.
3. At one week, the total reported pain levels were similar in both groups, suggesting that group A was not inferior to group B.
4. Group A had considerably lower average pain scores and the lowest pain intensity levels.
5. There was no statistically significant difference between groups in terms of unused pills or constipation.
Urologists are acutely aware of the need of avoiding drugs following surgery wherever feasible, and several groups have implemented opioid-sparing or opioid-avoiding protocols. However, if these approaches for kidney stone surgery have not previously been created, this study should serve to justify their decision. Patients having kidney stone surgery will benefit from these initiatives as well. This study adds to the growing body of data that non-opioid analgesics, such as Ketorolac, are a viable alternative for pain control following non-invasive urologic operations.
Reference:
Demasi, M., Segall, M., Feiertag, N., Mengotto, A., Cuartas, P., Loloi, J., Ahn, J., Stern, J., Laudano, M., & Watts, K. (2022). MP31-01 MINIMIZING NARCOTICS: A RANDOMIZED-CONTROLLED TRIAL COMPARING PERCOCET TO KETOROLAC AFTER KIDNEY STONE SURGERY. In Journal of Urology (Vol. 207, Issue Supplement 5). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/ju.0000000000002580.01
Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751